HeartSciences Inc.
HSCS
$3.70
$0.010.27%
NASDAQ
07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
---|---|---|---|---|---|
Revenue | 6.30K | 4.40K | 0.00 | 14.70K | 18.60K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.30K | 4.40K | 0.00 | 14.70K | 18.60K |
Cost of Revenue | 2.70K | 1.90K | 0.00 | 4.60K | 6.10K |
Gross Profit | 3.60K | 2.50K | 0.00 | 10.10K | 12.50K |
SG&A Expenses | 4.00M | 3.97M | 3.81M | 3.50M | 3.53M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.16M | 8.36M | 8.31M | 7.48M | 7.07M |
Operating Income | -8.15M | -8.35M | -8.31M | -7.47M | -7.05M |
Income Before Tax | -8.77M | -8.77M | -8.52M | -7.62M | -7.29M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -8.77 | -8.77 | -8.52 | -7.62 | -7.29 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -8.77M | -8.77M | -8.52M | -7.62M | -7.29M |
EBIT | -8.15M | -8.35M | -8.31M | -7.47M | -7.05M |
EBITDA | -8.12M | -8.32M | -8.27M | -7.43M | -7.02M |
EPS Basic | -8.37 | -9.44 | -10.31 | -10.74 | -24.39 |
Normalized Basic EPS | -5.23 | -5.90 | -6.44 | -6.72 | -15.24 |
EPS Diluted | -8.37 | -9.44 | -10.31 | -10.74 | -24.39 |
Normalized Diluted EPS | -5.23 | -5.90 | -6.44 | -6.72 | -15.24 |
Average Basic Shares Outstanding | 4.28M | 3.75M | 3.33M | 2.89M | 2.09M |
Average Diluted Shares Outstanding | 4.28M | 3.75M | 3.33M | 2.89M | 2.09M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |